Structure

Physi-Chem Properties

Molecular Weight:  346.18
Volume:  359.576
LogP:  3.583
LogD:  2.547
LogS:  -4.367
# Rotatable Bonds:  2
TPSA:  83.83
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.798
Synthetic Accessibility Score:  4.1
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.831
MDCK Permeability:  1.748245267663151e-05
Pgp-inhibitor:  0.303
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.041
20% Bioavailability (F20%):  0.725
30% Bioavailability (F30%):  0.312

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.25
Plasma Protein Binding (PPB):  96.32611083984375%
Volume Distribution (VD):  1.426
Pgp-substrate:  3.2831332683563232%

ADMET: Metabolism

CYP1A2-inhibitor:  0.589
CYP1A2-substrate:  0.966
CYP2C19-inhibitor:  0.271
CYP2C19-substrate:  0.854
CYP2C9-inhibitor:  0.669
CYP2C9-substrate:  0.89
CYP2D6-inhibitor:  0.285
CYP2D6-substrate:  0.257
CYP3A4-inhibitor:  0.424
CYP3A4-substrate:  0.58

ADMET: Excretion

Clearance (CL):  3.976
Half-life (T1/2):  0.211

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.192
Drug-inuced Liver Injury (DILI):  0.462
AMES Toxicity:  0.07
Rat Oral Acute Toxicity:  0.214
Maximum Recommended Daily Dose:  0.178
Skin Sensitization:  0.416
Carcinogencity:  0.14
Eye Corrosion:  0.003
Eye Irritation:  0.672
Respiratory Toxicity:  0.949

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC283301

Natural Product ID:  NPC283301
Common Name*:   Taiwaniaquinol F
IUPAC Name:   (4aS,9aS)-5,8-dihydroxy-6-methoxy-1,1,4a-trimethyl-7-propan-2-yl-4,9a-dihydro-3H-fluorene-2,9-dione
Synonyms:   Taiwaniaquinol F
Standard InCHIKey:  VIRHHCMHBQFERA-UYAOXDASSA-N
Standard InCHI:  InChI=1S/C20H26O5/c1-9(2)11-14(22)12-13(16(24)17(11)25-6)20(5)8-7-10(21)19(3,4)18(20)15(12)23/h9,18,22,24H,7-8H2,1-6H3/t18-,20-/m1/s1
SMILES:  COc1c(C(C)C)c(O)c2c(c1O)[C@@]1(C)CCC(=O)C([C@H]1C2=O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1087414
PubChem CID:   46880979
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. twig n.a. PMID[22474975]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[31347365]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[9014350]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO24241 Taiwania cryptomerioides Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens EC50 > 10000.0 nM PMID[558160]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC283301 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC276815
0.9933 High Similarity NPC25850
0.9536 High Similarity NPC273248
0.947 High Similarity NPC161778
0.9216 High Similarity NPC218628
0.9211 High Similarity NPC50269
0.9119 High Similarity NPC102372
0.9057 High Similarity NPC173587
0.9057 High Similarity NPC208120
0.9006 High Similarity NPC232936
0.9 High Similarity NPC146584
0.9 High Similarity NPC21016
0.8974 High Similarity NPC472048
0.8951 High Similarity NPC213416
0.8938 High Similarity NPC475055
0.8938 High Similarity NPC29055
0.8868 High Similarity NPC84571
0.8812 High Similarity NPC311740
0.875 High Similarity NPC155302
0.875 High Similarity NPC161947
0.8742 High Similarity NPC37543
0.8742 High Similarity NPC92079
0.8742 High Similarity NPC179732
0.8742 High Similarity NPC199463
0.8704 High Similarity NPC270837
0.8704 High Similarity NPC220313
0.8704 High Similarity NPC236132
0.8696 High Similarity NPC87431
0.8696 High Similarity NPC65746
0.8688 High Similarity NPC45846
0.8679 High Similarity NPC470762
0.8679 High Similarity NPC14561
0.8679 High Similarity NPC5379
0.8679 High Similarity NPC48105
0.8679 High Similarity NPC474167
0.8679 High Similarity NPC77807
0.8642 High Similarity NPC294965
0.8642 High Similarity NPC470694
0.8634 High Similarity NPC14353
0.8634 High Similarity NPC56085
0.8634 High Similarity NPC228785
0.8625 High Similarity NPC178976
0.8589 High Similarity NPC187491
0.8589 High Similarity NPC319200
0.8589 High Similarity NPC476822
0.858 High Similarity NPC40491
0.858 High Similarity NPC32694
0.858 High Similarity NPC66288
0.858 High Similarity NPC61010
0.858 High Similarity NPC278052
0.8571 High Similarity NPC100123
0.8553 High Similarity NPC107109
0.8553 High Similarity NPC477048
0.8553 High Similarity NPC477047
0.8537 High Similarity NPC473286
0.8537 High Similarity NPC25361
0.8537 High Similarity NPC26386
0.8537 High Similarity NPC326520
0.8528 High Similarity NPC215612
0.8526 High Similarity NPC251188
0.8519 High Similarity NPC119224
0.8519 High Similarity NPC235018
0.8519 High Similarity NPC80375
0.8519 High Similarity NPC45146
0.8519 High Similarity NPC320359
0.8509 High Similarity NPC241904
0.8509 High Similarity NPC217677
0.8509 High Similarity NPC300727
0.8509 High Similarity NPC165977
0.8503 High Similarity NPC158226
0.85 High Similarity NPC130589
0.85 High Similarity NPC134287
0.85 High Similarity NPC234485
0.8494 Intermediate Similarity NPC165979
0.8494 Intermediate Similarity NPC163130
0.8485 Intermediate Similarity NPC37870
0.8485 Intermediate Similarity NPC170245
0.8481 Intermediate Similarity NPC472279
0.8481 Intermediate Similarity NPC103509
0.8476 Intermediate Similarity NPC197168
0.8476 Intermediate Similarity NPC101769
0.8476 Intermediate Similarity NPC7483
0.8476 Intermediate Similarity NPC152659
0.8476 Intermediate Similarity NPC248638
0.8476 Intermediate Similarity NPC236521
0.8471 Intermediate Similarity NPC15329
0.8471 Intermediate Similarity NPC131451
0.8466 Intermediate Similarity NPC472275
0.8457 Intermediate Similarity NPC476242
0.8457 Intermediate Similarity NPC235448
0.8447 Intermediate Similarity NPC274730
0.8447 Intermediate Similarity NPC142339
0.8438 Intermediate Similarity NPC93552
0.8438 Intermediate Similarity NPC127172
0.8434 Intermediate Similarity NPC126204
0.8424 Intermediate Similarity NPC239752
0.8424 Intermediate Similarity NPC275780
0.8424 Intermediate Similarity NPC472450
0.8418 Intermediate Similarity NPC303989
0.8418 Intermediate Similarity NPC102003
0.8418 Intermediate Similarity NPC92722
0.8418 Intermediate Similarity NPC134293
0.8415 Intermediate Similarity NPC25152
0.8412 Intermediate Similarity NPC77179
0.8412 Intermediate Similarity NPC23553
0.8405 Intermediate Similarity NPC475886
0.8405 Intermediate Similarity NPC474287
0.8395 Intermediate Similarity NPC236796
0.8395 Intermediate Similarity NPC36852
0.8395 Intermediate Similarity NPC302258
0.8395 Intermediate Similarity NPC469584
0.8395 Intermediate Similarity NPC262286
0.8395 Intermediate Similarity NPC180011
0.8395 Intermediate Similarity NPC219867
0.8395 Intermediate Similarity NPC79053
0.8395 Intermediate Similarity NPC78225
0.8395 Intermediate Similarity NPC78103
0.8385 Intermediate Similarity NPC39184
0.8383 Intermediate Similarity NPC475805
0.8383 Intermediate Similarity NPC476637
0.8383 Intermediate Similarity NPC99613
0.8383 Intermediate Similarity NPC49487
0.8375 Intermediate Similarity NPC312338
0.8375 Intermediate Similarity NPC149889
0.8375 Intermediate Similarity NPC20337
0.8373 Intermediate Similarity NPC29160
0.8373 Intermediate Similarity NPC472452
0.8373 Intermediate Similarity NPC39091
0.8372 Intermediate Similarity NPC246153
0.8372 Intermediate Similarity NPC182693
0.8372 Intermediate Similarity NPC228209
0.8372 Intermediate Similarity NPC240508
0.8365 Intermediate Similarity NPC294646
0.8364 Intermediate Similarity NPC303460
0.8364 Intermediate Similarity NPC473313
0.8364 Intermediate Similarity NPC23298
0.8364 Intermediate Similarity NPC207690
0.8364 Intermediate Similarity NPC475985
0.8364 Intermediate Similarity NPC472278
0.8364 Intermediate Similarity NPC146134
0.8364 Intermediate Similarity NPC306321
0.8364 Intermediate Similarity NPC18100
0.8364 Intermediate Similarity NPC472281
0.8364 Intermediate Similarity NPC329669
0.8364 Intermediate Similarity NPC133065
0.8364 Intermediate Similarity NPC205265
0.8364 Intermediate Similarity NPC189473
0.8363 Intermediate Similarity NPC120102
0.8354 Intermediate Similarity NPC474187
0.8354 Intermediate Similarity NPC474186
0.8354 Intermediate Similarity NPC474351
0.8354 Intermediate Similarity NPC476058
0.8354 Intermediate Similarity NPC475883
0.8354 Intermediate Similarity NPC287395
0.8354 Intermediate Similarity NPC183655
0.8354 Intermediate Similarity NPC266314
0.8354 Intermediate Similarity NPC278427
0.8344 Intermediate Similarity NPC477410
0.8344 Intermediate Similarity NPC185258
0.8344 Intermediate Similarity NPC250214
0.8344 Intermediate Similarity NPC95936
0.8344 Intermediate Similarity NPC172770
0.8344 Intermediate Similarity NPC315157
0.8344 Intermediate Similarity NPC85121
0.8333 Intermediate Similarity NPC68093
0.8333 Intermediate Similarity NPC109827
0.8333 Intermediate Similarity NPC115853
0.8333 Intermediate Similarity NPC101107
0.8333 Intermediate Similarity NPC191146
0.8333 Intermediate Similarity NPC472276
0.8333 Intermediate Similarity NPC240808
0.8333 Intermediate Similarity NPC124470
0.8333 Intermediate Similarity NPC138243
0.8323 Intermediate Similarity NPC6588
0.8323 Intermediate Similarity NPC250557
0.8323 Intermediate Similarity NPC477154
0.8323 Intermediate Similarity NPC11314
0.8323 Intermediate Similarity NPC89474
0.8323 Intermediate Similarity NPC124714
0.8323 Intermediate Similarity NPC117854
0.8323 Intermediate Similarity NPC234331
0.8313 Intermediate Similarity NPC19980
0.8313 Intermediate Similarity NPC272566
0.8313 Intermediate Similarity NPC472277
0.8313 Intermediate Similarity NPC302783
0.8313 Intermediate Similarity NPC39306
0.8313 Intermediate Similarity NPC75377
0.8313 Intermediate Similarity NPC473201
0.8313 Intermediate Similarity NPC45291
0.8304 Intermediate Similarity NPC221820
0.8303 Intermediate Similarity NPC81679
0.8303 Intermediate Similarity NPC52204
0.8303 Intermediate Similarity NPC144843
0.8303 Intermediate Similarity NPC229632
0.8294 Intermediate Similarity NPC139350
0.8294 Intermediate Similarity NPC245975
0.8294 Intermediate Similarity NPC227906
0.8293 Intermediate Similarity NPC185617
0.8293 Intermediate Similarity NPC200746
0.8293 Intermediate Similarity NPC246478

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC283301 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8373 Intermediate Similarity NPD7473 Discontinued
0.8303 Intermediate Similarity NPD6232 Discontinued
0.821 Intermediate Similarity NPD2801 Approved
0.8165 Intermediate Similarity NPD2533 Approved
0.8165 Intermediate Similarity NPD2532 Approved
0.8165 Intermediate Similarity NPD2534 Approved
0.8039 Intermediate Similarity NPD6651 Approved
0.7988 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD2800 Approved
0.7927 Intermediate Similarity NPD1934 Approved
0.7892 Intermediate Similarity NPD3882 Suspended
0.7857 Intermediate Similarity NPD5494 Approved
0.7654 Intermediate Similarity NPD1511 Approved
0.7644 Intermediate Similarity NPD5844 Phase 1
0.7602 Intermediate Similarity NPD6959 Discontinued
0.7586 Intermediate Similarity NPD3818 Discontinued
0.7572 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD6166 Phase 2
0.7572 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1512 Approved
0.7558 Intermediate Similarity NPD5711 Approved
0.7558 Intermediate Similarity NPD5710 Approved
0.75 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4380 Phase 2
0.7484 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1607 Approved
0.7456 Intermediate Similarity NPD1465 Phase 2
0.7418 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD3817 Phase 2
0.7401 Intermediate Similarity NPD7074 Phase 3
0.7384 Intermediate Similarity NPD6234 Discontinued
0.7381 Intermediate Similarity NPD6599 Discontinued
0.7374 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7819 Suspended
0.7345 Intermediate Similarity NPD7054 Approved
0.7342 Intermediate Similarity NPD1240 Approved
0.7342 Intermediate Similarity NPD943 Approved
0.7329 Intermediate Similarity NPD2935 Discontinued
0.7303 Intermediate Similarity NPD7472 Approved
0.7299 Intermediate Similarity NPD1247 Approved
0.7294 Intermediate Similarity NPD37 Approved
0.7289 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1510 Phase 2
0.7267 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD7390 Discontinued
0.7225 Intermediate Similarity NPD7075 Discontinued
0.7222 Intermediate Similarity NPD6099 Approved
0.7222 Intermediate Similarity NPD6100 Approved
0.7216 Intermediate Similarity NPD3926 Phase 2
0.7209 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7199 Phase 2
0.7186 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD4967 Phase 2
0.7168 Intermediate Similarity NPD4965 Approved
0.7168 Intermediate Similarity NPD4966 Approved
0.7167 Intermediate Similarity NPD6797 Phase 2
0.7158 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD7251 Discontinued
0.7127 Intermediate Similarity NPD6559 Discontinued
0.7119 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3226 Approved
0.7107 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7228 Approved
0.7093 Intermediate Similarity NPD6801 Discontinued
0.7088 Intermediate Similarity NPD7808 Phase 3
0.7081 Intermediate Similarity NPD230 Phase 1
0.7073 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD1549 Phase 2
0.7029 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD6799 Approved
0.7 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.6989 Remote Similarity NPD919 Approved
0.6979 Remote Similarity NPD6779 Approved
0.6979 Remote Similarity NPD6778 Approved
0.6979 Remote Similarity NPD6776 Approved
0.6979 Remote Similarity NPD6780 Approved
0.6979 Remote Similarity NPD6782 Approved
0.6979 Remote Similarity NPD6777 Approved
0.6979 Remote Similarity NPD6781 Approved
0.6978 Remote Similarity NPD7993 Clinical (unspecified phase)
0.697 Remote Similarity NPD2346 Discontinued
0.6961 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4628 Phase 3
0.6946 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3027 Phase 3
0.6936 Remote Similarity NPD7411 Suspended
0.6935 Remote Similarity NPD8434 Phase 2
0.6932 Remote Similarity NPD3749 Approved
0.6914 Remote Similarity NPD5402 Approved
0.6914 Remote Similarity NPD3620 Phase 2
0.6914 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6909 Remote Similarity NPD2796 Approved
0.6893 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6891 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6879 Remote Similarity NPD7028 Phase 2
0.6872 Remote Similarity NPD7435 Discontinued
0.6869 Remote Similarity NPD8151 Discontinued
0.6848 Remote Similarity NPD7685 Pre-registration
0.6845 Remote Similarity NPD3750 Approved
0.6845 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6845 Remote Similarity NPD8150 Discontinued
0.6821 Remote Similarity NPD7458 Discontinued
0.6816 Remote Similarity NPD8127 Discontinued
0.6813 Remote Similarity NPD9494 Approved
0.6806 Remote Similarity NPD6535 Approved
0.6806 Remote Similarity NPD6534 Approved
0.6802 Remote Similarity NPD920 Approved
0.6796 Remote Similarity NPD7852 Clinical (unspecified phase)
0.679 Remote Similarity NPD7985 Registered
0.6786 Remote Similarity NPD7696 Phase 3
0.6786 Remote Similarity NPD7698 Approved
0.6786 Remote Similarity NPD7697 Approved
0.678 Remote Similarity NPD7768 Phase 2
0.6774 Remote Similarity NPD8312 Approved
0.6774 Remote Similarity NPD8313 Approved
0.6768 Remote Similarity NPD447 Suspended
0.6766 Remote Similarity NPD2344 Approved
0.6761 Remote Similarity NPD5761 Phase 2
0.6761 Remote Similarity NPD5760 Phase 2
0.6751 Remote Similarity NPD7871 Phase 2
0.6751 Remote Similarity NPD7870 Phase 2
0.6747 Remote Similarity NPD2799 Discontinued
0.6746 Remote Similarity NPD7003 Approved
0.6734 Remote Similarity NPD7701 Phase 2
0.673 Remote Similarity NPD1876 Approved
0.6725 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6721 Remote Similarity NPD3751 Discontinued
0.672 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6716 Remote Similarity NPD7801 Approved
0.6708 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6707 Remote Similarity NPD5406 Approved
0.6707 Remote Similarity NPD5405 Approved
0.6707 Remote Similarity NPD5408 Approved
0.6707 Remote Similarity NPD5404 Approved
0.6707 Remote Similarity NPD1551 Phase 2
0.6703 Remote Similarity NPD2403 Approved
0.6703 Remote Similarity NPD5953 Discontinued
0.6701 Remote Similarity NPD7700 Phase 2
0.6701 Remote Similarity NPD7699 Phase 2
0.6687 Remote Similarity NPD1470 Approved
0.6686 Remote Similarity NPD6674 Discontinued
0.6686 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6686 Remote Similarity NPD1243 Approved
0.6685 Remote Similarity NPD7286 Phase 2
0.6667 Remote Similarity NPD7874 Approved
0.6667 Remote Similarity NPD7240 Approved
0.6667 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1529 Clinical (unspecified phase)
0.665 Remote Similarity NPD6823 Phase 2
0.6649 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6629 Remote Similarity NPD5978 Approved
0.6629 Remote Similarity NPD5977 Approved
0.6625 Remote Similarity NPD6696 Suspended
0.6608 Remote Similarity NPD2309 Approved
0.6606 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6606 Remote Similarity NPD1613 Approved
0.6604 Remote Similarity NPD9269 Phase 2
0.6604 Remote Similarity NPD3972 Approved
0.6596 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6593 Remote Similarity NPD3787 Discontinued
0.6593 Remote Similarity NPD7229 Phase 3
0.659 Remote Similarity NPD642 Clinical (unspecified phase)
0.6588 Remote Similarity NPD2654 Approved
0.6588 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6581 Remote Similarity NPD7340 Approved
0.658 Remote Similarity NPD6213 Phase 3
0.658 Remote Similarity NPD6212 Phase 3
0.658 Remote Similarity NPD6214 Clinical (unspecified phase)
0.657 Remote Similarity NPD3300 Phase 2
0.657 Remote Similarity NPD4665 Approved
0.657 Remote Similarity NPD4111 Phase 1
0.6557 Remote Similarity NPD5242 Approved
0.6552 Remote Similarity NPD7783 Phase 2
0.6552 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6552 Remote Similarity NPD6273 Approved
0.655 Remote Similarity NPD8166 Discontinued
0.655 Remote Similarity NPD4109 Clinical (unspecified phase)
0.655 Remote Similarity NPD4110 Phase 3
0.6548 Remote Similarity NPD3748 Approved
0.6541 Remote Similarity NPD1201 Approved
0.6536 Remote Similarity NPD5353 Approved
0.6524 Remote Similarity NPD4625 Phase 3
0.6522 Remote Similarity NPD1283 Approved
0.6519 Remote Similarity NPD3019 Approved
0.6519 Remote Similarity NPD2932 Approved
0.6515 Remote Similarity NPD2494 Approved
0.6515 Remote Similarity NPD2493 Approved
0.6514 Remote Similarity NPD5403 Approved
0.6512 Remote Similarity NPD6190 Approved
0.6507 Remote Similarity NPD7907 Approved
0.65 Remote Similarity NPD4583 Approved
0.65 Remote Similarity NPD4582 Approved
0.6494 Remote Similarity NPD1398 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data